Company Filing History:
Years Active: 2016-2024
Title: Remy Henri Luthringer: Innovator in Pharmaceuticals
Introduction
Remy Henri Luthringer is a distinguished inventor based in Geneva, Switzerland, known for his significant contributions to the pharmaceutical industry. With a portfolio of 10 patents, Luthringer has innovated key therapeutic solutions that address various health issues. His work has particularly focused on drug delivery systems and compounds that target complex disorders.
Latest Patents
Among his latest inventions are two notable patents. The first, titled "Gastro-resistant controlled release oral dosage forms," discloses gastro-resistant, controlled-release dosage forms comprising a specific compound or its pharmaceutically acceptable salt and/or solvate. These innovative dosage forms are designed to reduce the risk of QT prolongation in patients, particularly benefiting those diagnosed with schizophrenia by addressing negative symptoms associated with the condition.
His second patent, "Sigma ligand compounds and uses thereof," pertains to compounds useful for modulating Sigma receptors, demonstrating antiviral activity. This invention has potential applications in the treatment and prevention of pain disorders, neurological disorders such as Parkinson's disease and Alzheimer's disease, and certain types of cancer.
Career Highlights
Throughout his career, Remy Luthringer has worked with notable companies, including Minerva Neurosciences, Inc. and Cyrenaic Pharmaceuticals, Inc. His innovative spirit has driven him to combine pharmaceutical science with cutting-edge technology, particularly in areas that safeguard and enhance patient health.
Collaborations
Luthringer has collaborated with talented individuals in the field, including Nadine Noel and Sandra Werner. These partnerships have allowed for the exchange of ideas and expertise, fostering an environment of creativity and innovation.
Conclusion
Remy Henri Luthringer's contributions to the pharmaceutical landscape exemplify the vital role inventors play in addressing health challenges. With a focus on controlled release and effective therapeutic agents, his work continues to impact the lives of many, showcasing the importance of innovation in medicine.